JP2006522033A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006522033A5 JP2006522033A5 JP2006504581A JP2006504581A JP2006522033A5 JP 2006522033 A5 JP2006522033 A5 JP 2006522033A5 JP 2006504581 A JP2006504581 A JP 2006504581A JP 2006504581 A JP2006504581 A JP 2006504581A JP 2006522033 A5 JP2006522033 A5 JP 2006522033A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- oxomorpholin
- chlorophenyl
- dicarboxamide
- carboxamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 3-oxomorpholin-4-yl Chemical group 0.000 claims description 60
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 49
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 40
- RVEDFFORAVMBLV-UHFFFAOYSA-N pyrrolidine-1,2-dicarboxamide Chemical compound NC(=O)C1CCCN1C(N)=O RVEDFFORAVMBLV-UHFFFAOYSA-N 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 3
- HVHPEBUXEYCYLB-RTBURBONSA-N (2r,4r)-1-n-(4-chlorophenyl)-4-hydroxy-2-n-[4-(2-imino-5-methyl-1,3-thiazol-3-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N=C1SC(C)=CN1C(C=C1)=CC=C1NC(=O)[C@@H]1N(C(=O)NC=2C=CC(Cl)=CC=2)C[C@H](O)C1 HVHPEBUXEYCYLB-RTBURBONSA-N 0.000 claims description 2
- YYBKOFKTRQCDEW-UYAOXDASSA-N (2r,4r)-1-n-(4-chlorophenyl)-4-hydroxy-2-n-[4-(2-iminopyrrolidin-1-yl)-3-methylphenyl]pyrrolidine-1,2-dicarboxamide Chemical compound C([C@H](O)C[C@@H]1C(=O)NC=2C=C(C(=CC=2)N2C(CCC2)=N)C)N1C(=O)NC1=CC=C(Cl)C=C1 YYBKOFKTRQCDEW-UYAOXDASSA-N 0.000 claims description 2
- QKGVCFWQZGNPBC-RTBURBONSA-N (2r,4r)-1-n-(4-chlorophenyl)-4-hydroxy-2-n-[4-(2-iminopyrrolidin-1-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C=CC(=CC=1)N1C(CCC1)=N)C(=O)NC1=CC=C(Cl)C=C1 QKGVCFWQZGNPBC-RTBURBONSA-N 0.000 claims description 2
- PPWOXIYNZVZCTN-VQIMIIECSA-N (2r,4r)-2-n-[2-carbamoyl-4-(3-oxomorpholin-4-yl)phenyl]-1-n-(4-chlorophenyl)-4-hydroxypyrrolidine-1,2-dicarboxamide Chemical compound C([C@H](O)C[C@@H]1C(=O)NC2=CC=C(C=C2C(=O)N)N2C(COCC2)=O)N1C(=O)NC1=CC=C(Cl)C=C1 PPWOXIYNZVZCTN-VQIMIIECSA-N 0.000 claims description 2
- LHJVCEMMLRHHSK-HNAYVOBHSA-N (2r,4s)-4-amino-1-n-(4-chlorophenyl)-2-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@@H](C1)N)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)NC1=CC=C(Cl)C=C1 LHJVCEMMLRHHSK-HNAYVOBHSA-N 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 claims 3
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 claims 3
- DVAWMFRCYCIUAC-VQIMIIECSA-N (2r,4r)-1-n-(4-chlorophenyl)-2-n-[2-fluoro-4-(3-oxomorpholin-4-yl)phenyl]-4-hydroxypyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C(=CC(=CC=1)N1C(COCC1)=O)F)C(=O)NC1=CC=C(Cl)C=C1 DVAWMFRCYCIUAC-VQIMIIECSA-N 0.000 claims 2
- DMYZJLOWGSRVKP-RTBURBONSA-N (2r,4r)-1-n-(4-chlorophenyl)-4-hydroxy-2-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)NC1=CC=C(Cl)C=C1 DMYZJLOWGSRVKP-RTBURBONSA-N 0.000 claims 2
- GKGWERVBDCNFHU-HXUWFJFHSA-N (2r)-1-n-(4-chlorophenyl)-2-n-[2-fluoro-4-(2-oxopyridin-1-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound C([C@@H]1C(=O)NC2=CC=C(C=C2F)N2C(C=CC=C2)=O)CCN1C(=O)NC1=CC=C(Cl)C=C1 GKGWERVBDCNFHU-HXUWFJFHSA-N 0.000 claims 1
- JWMWLAIBJDOWAB-LJQANCHMSA-N (2r)-1-n-(4-chlorophenyl)-2-n-[2-fluoro-4-(3-oxomorpholin-4-yl)phenyl]-2,5-dihydropyrrole-1,2-dicarboxamide Chemical compound C([C@@H]1C(=O)NC2=CC=C(C=C2F)N2C(COCC2)=O)=CCN1C(=O)NC1=CC=C(Cl)C=C1 JWMWLAIBJDOWAB-LJQANCHMSA-N 0.000 claims 1
- QAEPOQNAPBZBFO-LJQANCHMSA-N (2r)-1-n-(4-chlorophenyl)-2-n-[2-fluoro-4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound C([C@@H]1C(=O)NC2=CC=C(C=C2F)N2C(COCC2)=O)CCN1C(=O)NC1=CC=C(Cl)C=C1 QAEPOQNAPBZBFO-LJQANCHMSA-N 0.000 claims 1
- NFLNBMYZGDHTIO-LJQANCHMSA-N (2r)-1-n-(4-chlorophenyl)-2-n-[3-fluoro-4-(3-oxomorpholin-4-yl)phenyl]-2,5-dihydropyrrole-1,2-dicarboxamide Chemical compound C([C@@H]1C(=O)NC=2C=C(C(=CC=2)N2C(COCC2)=O)F)=CCN1C(=O)NC1=CC=C(Cl)C=C1 NFLNBMYZGDHTIO-LJQANCHMSA-N 0.000 claims 1
- GOOGYBKROAIFSP-LJQANCHMSA-N (2r)-1-n-(4-chlorophenyl)-2-n-[3-fluoro-4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound C([C@@H]1C(=O)NC=2C=C(C(=CC=2)N2C(COCC2)=O)F)CCN1C(=O)NC1=CC=C(Cl)C=C1 GOOGYBKROAIFSP-LJQANCHMSA-N 0.000 claims 1
- KGRFFJZSQMZGNV-OAQYLSRUSA-N (2r)-1-n-(4-chlorophenyl)-2-n-[3-methyl-4-(3-oxomorpholin-4-yl)phenyl]piperidine-1,2-dicarboxamide Chemical compound C([C@@H]1C(=O)NC=2C=C(C(=CC=2)N2C(COCC2)=O)C)CCCN1C(=O)NC1=CC=C(Cl)C=C1 KGRFFJZSQMZGNV-OAQYLSRUSA-N 0.000 claims 1
- FJDROJBPSMOTGQ-HXUWFJFHSA-N (2r)-1-n-(4-chlorophenyl)-2-n-[3-methyl-4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound C([C@@H]1C(=O)NC=2C=C(C(=CC=2)N2C(COCC2)=O)C)CCN1C(=O)NC1=CC=C(Cl)C=C1 FJDROJBPSMOTGQ-HXUWFJFHSA-N 0.000 claims 1
- GGHPMOKDRZKXAP-LJQANCHMSA-N (2r)-1-n-(4-chlorophenyl)-2-n-[4-(2-oxopyrazin-1-yl)phenyl]-2,5-dihydropyrrole-1,2-dicarboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)N1[C@@H](C(=O)NC=2C=CC(=CC=2)N2C(C=NC=C2)=O)C=CC1 GGHPMOKDRZKXAP-LJQANCHMSA-N 0.000 claims 1
- XRNPHSUEJXAARO-LJQANCHMSA-N (2r)-1-n-(4-chlorophenyl)-2-n-[4-(2-oxopyrazin-1-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)N1[C@@H](C(=O)NC=2C=CC(=CC=2)N2C(C=NC=C2)=O)CCC1 XRNPHSUEJXAARO-LJQANCHMSA-N 0.000 claims 1
- FTKRIFCRKDQKHX-HXUWFJFHSA-N (2r)-1-n-(4-chlorophenyl)-2-n-[4-(2-oxopyridin-1-yl)phenyl]-2,5-dihydropyrrole-1,2-dicarboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)N1[C@@H](C(=O)NC=2C=CC(=CC=2)N2C(C=CC=C2)=O)C=CC1 FTKRIFCRKDQKHX-HXUWFJFHSA-N 0.000 claims 1
- ZVRFEMHCIFXPIH-HXUWFJFHSA-N (2r)-1-n-(4-chlorophenyl)-2-n-[4-(2-oxopyridin-1-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)N1[C@@H](C(=O)NC=2C=CC(=CC=2)N2C(C=CC=C2)=O)CCC1 ZVRFEMHCIFXPIH-HXUWFJFHSA-N 0.000 claims 1
- WYJQOESFPMHBHQ-HXUWFJFHSA-N (2r)-1-n-(4-chlorophenyl)-2-n-[4-(3-methoxy-2-oxopyridin-1-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound O=C1C(OC)=CC=CN1C(C=C1)=CC=C1NC(=O)[C@@H]1N(C(=O)NC=2C=CC(Cl)=CC=2)CCC1 WYJQOESFPMHBHQ-HXUWFJFHSA-N 0.000 claims 1
- VKSGQOJQICOTAN-LJQANCHMSA-N (2r)-1-n-(4-chlorophenyl)-2-n-[4-(3-oxomorpholin-4-yl)-3-(trifluoromethyl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound C([C@@H]1C(=O)NC=2C=C(C(=CC=2)N2C(COCC2)=O)C(F)(F)F)CCN1C(=O)NC1=CC=C(Cl)C=C1 VKSGQOJQICOTAN-LJQANCHMSA-N 0.000 claims 1
- YULBOJOPWIZXBD-LJQANCHMSA-N (2r)-1-n-(4-chlorophenyl)-2-n-[4-(3-oxomorpholin-4-yl)phenyl]-2,5-dihydropyrrole-1,2-dicarboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)N1[C@@H](C(=O)NC=2C=CC(=CC=2)N2C(COCC2)=O)C=CC1 YULBOJOPWIZXBD-LJQANCHMSA-N 0.000 claims 1
- NMWKHENLIDHRCM-LJQANCHMSA-N (2r)-1-n-(4-chlorophenyl)-2-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)N1[C@@H](C(=O)NC=2C=CC(=CC=2)N2C(COCC2)=O)CCC1 NMWKHENLIDHRCM-LJQANCHMSA-N 0.000 claims 1
- QAFUBLOZJSGCNC-HXUWFJFHSA-N (2r)-1-n-(4-chlorophenyl)-2-n-[4-(5-oxo-1,4-oxazepan-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)N1[C@@H](C(=O)NC=2C=CC(=CC=2)N2C(CCOCC2)=O)CCC1 QAFUBLOZJSGCNC-HXUWFJFHSA-N 0.000 claims 1
- WNLPRJBAOOQMBC-FOIQADDNSA-N (2r)-1-n-(4-chlorophenyl)-2-n-[4-[(2r)-2-methyl-3-oxomorpholin-4-yl]phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound O=C1[C@@H](C)OCCN1C(C=C1)=CC=C1NC(=O)[C@@H]1N(C(=O)NC=2C=CC(Cl)=CC=2)CCC1 WNLPRJBAOOQMBC-FOIQADDNSA-N 0.000 claims 1
- WNLPRJBAOOQMBC-MGPUTAFESA-N (2r)-1-n-(4-chlorophenyl)-2-n-[4-[(2s)-2-methyl-3-oxomorpholin-4-yl]phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound O=C1[C@H](C)OCCN1C(C=C1)=CC=C1NC(=O)[C@@H]1N(C(=O)NC=2C=CC(Cl)=CC=2)CCC1 WNLPRJBAOOQMBC-MGPUTAFESA-N 0.000 claims 1
- VQXISNMZTFPINL-LJQANCHMSA-N (2r)-1-n-(4-chlorophenyl)-4,4-difluoro-2-n-[4-(2-oxopyridin-1-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](CC(C1)(F)F)C(=O)NC=1C=CC(=CC=1)N1C(C=CC=C1)=O)C(=O)NC1=CC=C(Cl)C=C1 VQXISNMZTFPINL-LJQANCHMSA-N 0.000 claims 1
- QBXCMKKONVCHGK-OAQYLSRUSA-N (2r)-1-n-(4-chlorophenyl)-4,4-dimethoxy-2-n-[4-(2-oxopyridin-1-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](CC(C1)(OC)OC)C(=O)NC=1C=CC(=CC=1)N1C(C=CC=C1)=O)C(=O)NC1=CC=C(Cl)C=C1 QBXCMKKONVCHGK-OAQYLSRUSA-N 0.000 claims 1
- XTPRCZLXYJLWRE-LJQANCHMSA-N (2r)-1-n-(4-chlorophenyl)-4-oxo-2-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)N1[C@@H](C(=O)NC=2C=CC(=CC=2)N2C(COCC2)=O)CC(=O)C1 XTPRCZLXYJLWRE-LJQANCHMSA-N 0.000 claims 1
- IWEQFIGHZBYXAF-LJQANCHMSA-N (2r)-1-n-(5-chloropyridin-2-yl)-4,4-dimethoxy-2-n-[4-(2-oxopyridin-1-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](CC(C1)(OC)OC)C(=O)NC=1C=CC(=CC=1)N1C(C=CC=C1)=O)C(=O)NC1=CC=C(Cl)C=N1 IWEQFIGHZBYXAF-LJQANCHMSA-N 0.000 claims 1
- RKFPRGWDNCNMCT-GOSISDBHSA-N (2r)-1-n-(5-chloropyridin-2-yl)-4,4-dimethoxy-2-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](CC(C1)(OC)OC)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)NC1=CC=C(Cl)C=N1 RKFPRGWDNCNMCT-GOSISDBHSA-N 0.000 claims 1
- RSTITRFVOKEISD-LJQANCHMSA-N (2r)-2-n-(4-chlorophenyl)-1-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)[C@@H]1N(C(=O)NC=2C=CC(=CC=2)N2C(COCC2)=O)CCC1 RSTITRFVOKEISD-LJQANCHMSA-N 0.000 claims 1
- JIJYRHDGXGCDJY-HXUWFJFHSA-N (2r)-n-(4-chlorophenyl)-1-[2-[4-(3-oxomorpholin-4-yl)phenyl]acetyl]pyrrolidine-2-carboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)[C@@H]1N(C(=O)CC=2C=CC(=CC=2)N2C(COCC2)=O)CCC1 JIJYRHDGXGCDJY-HXUWFJFHSA-N 0.000 claims 1
- MRTFUFLCZKAPAP-UYAOXDASSA-N (2r,3r)-1-n-(4-chlorophenyl)-2-n-[3-fluoro-4-(3-oxomorpholin-4-yl)phenyl]-3-hydroxypyrrolidine-1,2-dicarboxamide Chemical compound O=C([C@@H]1N(CC[C@H]1O)C(=O)NC=1C=CC(Cl)=CC=1)NC(C=C1F)=CC=C1N1CCOCC1=O MRTFUFLCZKAPAP-UYAOXDASSA-N 0.000 claims 1
- MRTFUFLCZKAPAP-AZUAARDMSA-N (2r,3s)-1-n-(4-chlorophenyl)-2-n-[3-fluoro-4-(3-oxomorpholin-4-yl)phenyl]-3-hydroxypyrrolidine-1,2-dicarboxamide Chemical compound O=C([C@@H]1N(CC[C@@H]1O)C(=O)NC=1C=CC(Cl)=CC=1)NC(C=C1F)=CC=C1N1CCOCC1=O MRTFUFLCZKAPAP-AZUAARDMSA-N 0.000 claims 1
- OOLHEGBMCONDON-MISYRCLQSA-N (2r,3s,4r)-1-n-(4-chlorophenyl)-3,4-dihydroxy-2-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound O=C([C@@H]1N(C[C@H]([C@H]1O)O)C(=O)NC=1C=CC(Cl)=CC=1)NC(C=C1)=CC=C1N1CCOCC1=O OOLHEGBMCONDON-MISYRCLQSA-N 0.000 claims 1
- OGSANWVJXQAIRN-RTBURBONSA-N (2r,4r)-1-(4-chlorobenzoyl)-4-hydroxy-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)C1=CC=C(Cl)C=C1 OGSANWVJXQAIRN-RTBURBONSA-N 0.000 claims 1
- OJCLBINXHNLSGK-LVLPYEQSSA-N (2r,4r)-1-[(e)-3-(1h-imidazol-5-yl)prop-2-enoyl]-4-methoxy-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)OC)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)\C=C\C1=CNC=N1 OJCLBINXHNLSGK-LVLPYEQSSA-N 0.000 claims 1
- VRENKQPFVKSKNL-POVKHUTMSA-N (2r,4r)-1-[(e)-3-(3,4-dichlorophenyl)prop-2-enoyl]-4-ethoxy-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)OCC)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)\C=C\C1=CC=C(Cl)C(Cl)=C1 VRENKQPFVKSKNL-POVKHUTMSA-N 0.000 claims 1
- DIZATURBOIZCLQ-SQHZKEONSA-N (2r,4r)-1-[(e)-3-(3,4-dichlorophenyl)prop-2-enoyl]-4-hydroxy-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)\C=C\C1=CC=C(Cl)C(Cl)=C1 DIZATURBOIZCLQ-SQHZKEONSA-N 0.000 claims 1
- IMCBDNWDQMOASV-OJACVWAZSA-N (2r,4r)-1-[(e)-3-(3,4-dichlorophenyl)prop-2-enoyl]-4-methoxy-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)OC)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)\C=C\C1=CC=C(Cl)C(Cl)=C1 IMCBDNWDQMOASV-OJACVWAZSA-N 0.000 claims 1
- YRXKBVOWOCXRGZ-WKQNUPFUSA-N (2r,4r)-1-[(e)-3-(4-bromothiophen-2-yl)prop-2-enoyl]-4-ethoxy-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)OCC)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)\C=C\C1=CC(Br)=CS1 YRXKBVOWOCXRGZ-WKQNUPFUSA-N 0.000 claims 1
- XZFHNWZOWYTEIX-IBMJZYDUSA-N (2r,4r)-1-[(e)-3-(4-bromothiophen-2-yl)prop-2-enoyl]-4-hydroxy-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)\C=C\C1=CC(Br)=CS1 XZFHNWZOWYTEIX-IBMJZYDUSA-N 0.000 claims 1
- WVSUJZMCQUKNIS-OWCINNQBSA-N (2r,4r)-1-[(e)-3-(4-chlorophenyl)prop-2-enoyl]-4-ethoxy-n-[2-fluoro-4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)OCC)C(=O)NC=1C(=CC(=CC=1)N1C(COCC1)=O)F)C(=O)\C=C\C1=CC=C(Cl)C=C1 WVSUJZMCQUKNIS-OWCINNQBSA-N 0.000 claims 1
- NUKDURHKWVHYHM-HFFNVBOQSA-N (2r,4r)-1-[(e)-3-(4-chlorophenyl)prop-2-enoyl]-4-ethoxy-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)OCC)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)\C=C\C1=CC=C(Cl)C=C1 NUKDURHKWVHYHM-HFFNVBOQSA-N 0.000 claims 1
- NDORMENFKGUSCW-RVPUNCECSA-N (2r,4r)-1-[(e)-3-(4-chlorophenyl)prop-2-enoyl]-4-hydroxy-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)\C=C\C1=CC=C(Cl)C=C1 NDORMENFKGUSCW-RVPUNCECSA-N 0.000 claims 1
- UBNHTTMGXFRXQW-IADXMVKGSA-N (2r,4r)-1-[(e)-3-(4-chlorophenyl)prop-2-enoyl]-4-methoxy-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)OC)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)\C=C\C1=CC=C(Cl)C=C1 UBNHTTMGXFRXQW-IADXMVKGSA-N 0.000 claims 1
- SCPDUNMFRMJEGW-OPASBBJXSA-N (2r,4r)-1-[(e)-3-(4-chlorophenyl)prop-2-enoyl]-n-[2-fluoro-4-(3-oxomorpholin-4-yl)phenyl]-4-hydroxypyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C(=CC(=CC=1)N1C(COCC1)=O)F)C(=O)\C=C\C1=CC=C(Cl)C=C1 SCPDUNMFRMJEGW-OPASBBJXSA-N 0.000 claims 1
- IKVVTUUAXNUPHN-PNPYJXOGSA-N (2r,4r)-1-[(e)-3-(4-chlorophenyl)prop-2-enoyl]-n-[2-fluoro-4-(3-oxomorpholin-4-yl)phenyl]-4-methoxypyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)OC)C(=O)NC=1C(=CC(=CC=1)N1C(COCC1)=O)F)C(=O)\C=C\C1=CC=C(Cl)C=C1 IKVVTUUAXNUPHN-PNPYJXOGSA-N 0.000 claims 1
- HUGUSWDNLIMRLP-YLJGDWCDSA-N (2r,4r)-1-[(e)-3-(5-bromothiophen-2-yl)prop-2-enoyl]-4-ethoxy-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)OCC)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)\C=C\C1=CC=C(Br)S1 HUGUSWDNLIMRLP-YLJGDWCDSA-N 0.000 claims 1
- VONHEKWLIUXQEA-ISQHREMWSA-N (2r,4r)-1-[(e)-3-(5-bromothiophen-2-yl)prop-2-enoyl]-4-hydroxy-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)\C=C\C1=CC=C(Br)S1 VONHEKWLIUXQEA-ISQHREMWSA-N 0.000 claims 1
- OVQPNACWVSKSDS-KZJOSYIESA-N (2r,4r)-1-[(e)-3-(5-chlorofuran-2-yl)prop-2-enoyl]-4-ethoxy-n-[2-fluoro-4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)OCC)C(=O)NC=1C(=CC(=CC=1)N1C(COCC1)=O)F)C(=O)\C=C\C1=CC=C(Cl)O1 OVQPNACWVSKSDS-KZJOSYIESA-N 0.000 claims 1
- HWHJBULUDUFHNL-VGKNGNLDSA-N (2r,4r)-1-[(e)-3-(5-chlorofuran-2-yl)prop-2-enoyl]-4-ethoxy-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)OCC)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)\C=C\C1=CC=C(Cl)O1 HWHJBULUDUFHNL-VGKNGNLDSA-N 0.000 claims 1
- KQRIVLHCTFXOJD-ISQHREMWSA-N (2r,4r)-1-[(e)-3-(5-chlorofuran-2-yl)prop-2-enoyl]-4-hydroxy-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)\C=C\C1=CC=C(Cl)O1 KQRIVLHCTFXOJD-ISQHREMWSA-N 0.000 claims 1
- DLAXXEYSIVTGEI-WIWRLWJOSA-N (2r,4r)-1-[(e)-3-(5-chlorofuran-2-yl)prop-2-enoyl]-4-methoxy-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)OC)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)\C=C\C1=CC=C(Cl)O1 DLAXXEYSIVTGEI-WIWRLWJOSA-N 0.000 claims 1
- ZQRFASVNMULFPK-DPYHJZQVSA-N (2r,4r)-1-[(e)-3-(5-chlorofuran-2-yl)prop-2-enoyl]-n-[2-fluoro-4-(3-oxomorpholin-4-yl)phenyl]-4-hydroxypyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C(=CC(=CC=1)N1C(COCC1)=O)F)C(=O)\C=C\C1=CC=C(Cl)O1 ZQRFASVNMULFPK-DPYHJZQVSA-N 0.000 claims 1
- DZPQDLICPWUVGM-HEIUPUGOSA-N (2r,4r)-1-[(e)-3-(5-chlorofuran-2-yl)prop-2-enoyl]-n-[2-fluoro-4-(3-oxomorpholin-4-yl)phenyl]-4-methoxypyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)OC)C(=O)NC=1C(=CC(=CC=1)N1C(COCC1)=O)F)C(=O)\C=C\C1=CC=C(Cl)O1 DZPQDLICPWUVGM-HEIUPUGOSA-N 0.000 claims 1
- DZDLFZMCXKMHPE-AXIKGPDFSA-N (2r,4r)-1-[(e)-3-(5-chlorothiophen-2-yl)prop-2-enoyl]-4-ethoxy-n-[2-fluoro-4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)OCC)C(=O)NC=1C(=CC(=CC=1)N1C(COCC1)=O)F)C(=O)\C=C\C1=CC=C(Cl)S1 DZDLFZMCXKMHPE-AXIKGPDFSA-N 0.000 claims 1
- ZVBQHQNMHPKYAS-YLJGDWCDSA-N (2r,4r)-1-[(e)-3-(5-chlorothiophen-2-yl)prop-2-enoyl]-4-ethoxy-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)OCC)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)\C=C\C1=CC=C(Cl)S1 ZVBQHQNMHPKYAS-YLJGDWCDSA-N 0.000 claims 1
- NXGZLZQEBCDACU-ISQHREMWSA-N (2r,4r)-1-[(e)-3-(5-chlorothiophen-2-yl)prop-2-enoyl]-4-hydroxy-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)\C=C\C1=CC=C(Cl)S1 NXGZLZQEBCDACU-ISQHREMWSA-N 0.000 claims 1
- XWTBUXPOIOHBQG-ZNQKSWCZSA-N (2r,4r)-1-[(e)-3-(5-chlorothiophen-2-yl)prop-2-enoyl]-4-methoxy-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)OC)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)\C=C\C1=CC=C(Cl)S1 XWTBUXPOIOHBQG-ZNQKSWCZSA-N 0.000 claims 1
- ZWMBWPCKAQLOIV-DPYHJZQVSA-N (2r,4r)-1-[(e)-3-(5-chlorothiophen-2-yl)prop-2-enoyl]-n-[2-fluoro-4-(3-oxomorpholin-4-yl)phenyl]-4-hydroxypyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C(=CC(=CC=1)N1C(COCC1)=O)F)C(=O)\C=C\C1=CC=C(Cl)S1 ZWMBWPCKAQLOIV-DPYHJZQVSA-N 0.000 claims 1
- KSOGDOVHNVOXBJ-WPMPWUEYSA-N (2r,4r)-1-[(e)-3-(5-chlorothiophen-2-yl)prop-2-enoyl]-n-[2-fluoro-4-(3-oxomorpholin-4-yl)phenyl]-4-methoxypyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)OC)C(=O)NC=1C(=CC(=CC=1)N1C(COCC1)=O)F)C(=O)\C=C\C1=CC=C(Cl)S1 KSOGDOVHNVOXBJ-WPMPWUEYSA-N 0.000 claims 1
- PENCVIBEYMZOBJ-WOJBJXKFSA-N (2r,4r)-1-[2-(4-chlorophenyl)acetyl]-4-hydroxy-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)CC1=CC=C(Cl)C=C1 PENCVIBEYMZOBJ-WOJBJXKFSA-N 0.000 claims 1
- JCDABEAZCDTMNJ-YLJYHZDGSA-N (2r,4r)-1-n-(4-bromophenyl)-2-n-[2-fluoro-4-(3-oxomorpholin-4-yl)phenyl]-4-methoxypyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)OC)C(=O)NC=1C(=CC(=CC=1)N1C(COCC1)=O)F)C(=O)NC1=CC=C(Br)C=C1 JCDABEAZCDTMNJ-YLJYHZDGSA-N 0.000 claims 1
- WVKUJJIWOVDBNJ-YLJYHZDGSA-N (2r,4r)-1-n-(4-chlorophenyl)-2-n-[2-fluoro-4-(3-oxomorpholin-4-yl)phenyl]-4-methoxypyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)OC)C(=O)NC=1C(=CC(=CC=1)N1C(COCC1)=O)F)C(=O)NC1=CC=C(Cl)C=C1 WVKUJJIWOVDBNJ-YLJYHZDGSA-N 0.000 claims 1
- YDVKNIOICPJAPC-YXKFXFPPSA-N (2r,4r)-1-n-(4-chlorophenyl)-2-n-[2-fluoro-4-[(2r)-2-methyl-3-oxomorpholin-4-yl]phenyl]-4-hydroxypyrrolidine-1,2-dicarboxamide Chemical compound O=C1[C@@H](C)OCCN1C(C=C1F)=CC=C1NC(=O)[C@@H]1N(C(=O)NC=2C=CC(Cl)=CC=2)C[C@H](O)C1 YDVKNIOICPJAPC-YXKFXFPPSA-N 0.000 claims 1
- CGCSRYFJSWKMTK-UYAOXDASSA-N (2r,4r)-1-n-(4-chlorophenyl)-4-(methanesulfonamido)-2-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)NS(=O)(=O)C)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)NC1=CC=C(Cl)C=C1 CGCSRYFJSWKMTK-UYAOXDASSA-N 0.000 claims 1
- ARFSZQDKDKCZAO-WIYYLYMNSA-N (2r,4r)-1-n-(4-chlorophenyl)-4-ethoxy-2-n-[2-fluoro-4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)OCC)C(=O)NC=1C(=CC(=CC=1)N1C(COCC1)=O)F)C(=O)NC1=CC=C(Cl)C=C1 ARFSZQDKDKCZAO-WIYYLYMNSA-N 0.000 claims 1
- JNFQAOAYJOVBOD-WIYYLYMNSA-N (2r,4r)-1-n-(4-chlorophenyl)-4-ethoxy-2-n-[3-fluoro-4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)OCC)C(=O)NC=1C=C(F)C(N2C(COCC2)=O)=CC=1)C(=O)NC1=CC=C(Cl)C=C1 JNFQAOAYJOVBOD-WIYYLYMNSA-N 0.000 claims 1
- QTIGFZSECDHJQV-IFMALSPDSA-N (2r,4r)-1-n-(4-chlorophenyl)-4-ethoxy-2-n-[3-methyl-4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)OCC)C(=O)NC=1C=C(C)C(N2C(COCC2)=O)=CC=1)C(=O)NC1=CC=C(Cl)C=C1 QTIGFZSECDHJQV-IFMALSPDSA-N 0.000 claims 1
- OWWZCAROLMFJOL-NHCUHLMSSA-N (2r,4r)-1-n-(4-chlorophenyl)-4-ethoxy-2-n-[4-(2-oxopyrazin-1-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)OCC)C(=O)NC=1C=CC(=CC=1)N1C(C=NC=C1)=O)C(=O)NC1=CC=C(Cl)C=C1 OWWZCAROLMFJOL-NHCUHLMSSA-N 0.000 claims 1
- QLBBJIWXJFZQLQ-FGZHOGPDSA-N (2r,4r)-1-n-(4-chlorophenyl)-4-ethoxy-2-n-[4-(2-oxopyridin-1-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)OCC)C(=O)NC=1C=CC(=CC=1)N1C(C=CC=C1)=O)C(=O)NC1=CC=C(Cl)C=C1 QLBBJIWXJFZQLQ-FGZHOGPDSA-N 0.000 claims 1
- MWCQXJXNQGSKRK-NHCUHLMSSA-N (2r,4r)-1-n-(4-chlorophenyl)-4-ethoxy-2-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)OCC)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)NC1=CC=C(Cl)C=C1 MWCQXJXNQGSKRK-NHCUHLMSSA-N 0.000 claims 1
- IQWIXQQERSPTFM-VQIMIIECSA-N (2r,4r)-1-n-(4-chlorophenyl)-4-hydroxy-2-n-[2-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C(=CC=CC=1)N1C(COCC1)=O)C(=O)NC1=CC=C(Cl)C=C1 IQWIXQQERSPTFM-VQIMIIECSA-N 0.000 claims 1
- UJNAWICJDFDXBV-UYAOXDASSA-N (2r,4r)-1-n-(4-chlorophenyl)-4-hydroxy-2-n-[2-methyl-4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound C([C@H](O)C[C@@H]1C(=O)NC2=CC=C(C=C2C)N2C(COCC2)=O)N1C(=O)NC1=CC=C(Cl)C=C1 UJNAWICJDFDXBV-UYAOXDASSA-N 0.000 claims 1
- GJIZHXIDKLJIOU-UYAOXDASSA-N (2r,4r)-1-n-(4-chlorophenyl)-4-hydroxy-2-n-[3-methyl-4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound C([C@H](O)C[C@@H]1C(=O)NC=2C=C(C(=CC=2)N2C(COCC2)=O)C)N1C(=O)NC1=CC=C(Cl)C=C1 GJIZHXIDKLJIOU-UYAOXDASSA-N 0.000 claims 1
- QTDGPOZESXBCMH-RTBURBONSA-N (2r,4r)-1-n-(4-chlorophenyl)-4-hydroxy-2-n-[4-(2-oxopyrazin-1-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C=CC(=CC=1)N1C(C=NC=C1)=O)C(=O)NC1=CC=C(Cl)C=C1 QTDGPOZESXBCMH-RTBURBONSA-N 0.000 claims 1
- KTLJCFXGKCOOII-WOJBJXKFSA-N (2r,4r)-1-n-(4-chlorophenyl)-4-hydroxy-2-n-[4-(2-oxopyridin-1-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C=CC(=CC=1)N1C(C=CC=C1)=O)C(=O)NC1=CC=C(Cl)C=C1 KTLJCFXGKCOOII-WOJBJXKFSA-N 0.000 claims 1
- HCHYXIXHMQEEEF-WOJBJXKFSA-N (2r,4r)-1-n-(4-chlorophenyl)-4-hydroxy-2-n-[4-(3-oxo-1,4-oxazepan-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C=CC(=CC=1)N1C(COCCC1)=O)C(=O)NC1=CC=C(Cl)C=C1 HCHYXIXHMQEEEF-WOJBJXKFSA-N 0.000 claims 1
- WXPKTJZAPWQNHQ-JDGDGYACSA-N (2r,4r)-1-n-(4-chlorophenyl)-4-hydroxy-2-n-[4-(3-oxomorpholin-4-yl)cyclohexyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC1CCC(CC1)N1C(COCC1)=O)C(=O)NC1=CC=C(Cl)C=C1 WXPKTJZAPWQNHQ-JDGDGYACSA-N 0.000 claims 1
- VODGOZUVFRFWJF-WOJBJXKFSA-N (2r,4r)-1-n-(4-chlorophenyl)-4-hydroxy-2-n-[4-(5-oxo-1,4-oxazepan-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C=CC(=CC=1)N1C(CCOCC1)=O)C(=O)NC1=CC=C(Cl)C=C1 VODGOZUVFRFWJF-WOJBJXKFSA-N 0.000 claims 1
- FFJAUUGFMHOZHX-JSNMRZPZSA-N (2r,4r)-1-n-(4-chlorophenyl)-4-hydroxy-2-n-[4-[(2r)-2-methyl-3-oxomorpholin-4-yl]phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound O=C1[C@@H](C)OCCN1C(C=C1)=CC=C1NC(=O)[C@@H]1N(C(=O)NC=2C=CC(Cl)=CC=2)C[C@H](O)C1 FFJAUUGFMHOZHX-JSNMRZPZSA-N 0.000 claims 1
- FFJAUUGFMHOZHX-VHKYSDTDSA-N (2r,4r)-1-n-(4-chlorophenyl)-4-hydroxy-2-n-[4-[(2s)-2-methyl-3-oxomorpholin-4-yl]phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound O=C1[C@H](C)OCCN1C(C=C1)=CC=C1NC(=O)[C@@H]1N(C(=O)NC=2C=CC(Cl)=CC=2)C[C@H](O)C1 FFJAUUGFMHOZHX-VHKYSDTDSA-N 0.000 claims 1
- NFVKHGYYDYOLJV-TZIWHRDSSA-N (2r,4r)-1-n-(4-chlorophenyl)-4-methoxy-2-n-[3-methyl-4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)OC)C(=O)NC=1C=C(C)C(N2C(COCC2)=O)=CC=1)C(=O)NC1=CC=C(Cl)C=C1 NFVKHGYYDYOLJV-TZIWHRDSSA-N 0.000 claims 1
- OGZWJYNVRNKYBP-WOJBJXKFSA-N (2r,4r)-1-n-(4-chlorophenyl)-4-methoxy-2-n-[4-(2-oxopyrazin-1-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)OC)C(=O)NC=1C=CC(=CC=1)N1C(C=NC=C1)=O)C(=O)NC1=CC=C(Cl)C=C1 OGZWJYNVRNKYBP-WOJBJXKFSA-N 0.000 claims 1
- REAPBLCNMXPQKC-NHCUHLMSSA-N (2r,4r)-1-n-(4-chlorophenyl)-4-methoxy-2-n-[4-(2-oxopyridin-1-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)OC)C(=O)NC=1C=CC(=CC=1)N1C(C=CC=C1)=O)C(=O)NC1=CC=C(Cl)C=C1 REAPBLCNMXPQKC-NHCUHLMSSA-N 0.000 claims 1
- VYFIQTNIYGLRPN-WOJBJXKFSA-N (2r,4r)-1-n-(4-chlorophenyl)-4-methoxy-2-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)OC)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)NC1=CC=C(Cl)C=C1 VYFIQTNIYGLRPN-WOJBJXKFSA-N 0.000 claims 1
- PHSLDILEKAJQER-CRAIPNDOSA-N (2r,4r)-1-n-(5-chloropyridin-2-yl)-2-n-[3-fluoro-4-(2-oxopyridin-1-yl)phenyl]-4-hydroxypyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C=C(F)C(=CC=1)N1C(C=CC=C1)=O)C(=O)NC1=CC=C(Cl)C=N1 PHSLDILEKAJQER-CRAIPNDOSA-N 0.000 claims 1
- LVJVEYCWZFBOOH-IAGOWNOFSA-N (2r,4r)-1-n-(5-chloropyridin-2-yl)-4-hydroxy-2-n-[4-(2-oxopyrazin-1-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C=CC(=CC=1)N1C(C=NC=C1)=O)C(=O)NC1=CC=C(Cl)C=N1 LVJVEYCWZFBOOH-IAGOWNOFSA-N 0.000 claims 1
- RYDJYYIWKQWQOP-QZTJIDSGSA-N (2r,4r)-1-n-(5-chloropyridin-2-yl)-4-hydroxy-2-n-[4-(2-oxopyridin-1-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C=CC(=CC=1)N1C(C=CC=C1)=O)C(=O)NC1=CC=C(Cl)C=N1 RYDJYYIWKQWQOP-QZTJIDSGSA-N 0.000 claims 1
- HVDDVGFDLLEPST-IAGOWNOFSA-N (2r,4r)-1-n-(5-chloropyridin-2-yl)-4-hydroxy-2-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)NC1=CC=C(Cl)C=N1 HVDDVGFDLLEPST-IAGOWNOFSA-N 0.000 claims 1
- VOFQCIKGOFPYOI-IAGOWNOFSA-N (2r,4r)-1-n-(6-chloropyridin-3-yl)-4-hydroxy-2-n-[4-(2-oxopyrazin-1-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C=CC(=CC=1)N1C(C=NC=C1)=O)C(=O)NC1=CC=C(Cl)N=C1 VOFQCIKGOFPYOI-IAGOWNOFSA-N 0.000 claims 1
- RVWDABVOSYZSMP-QZTJIDSGSA-N (2r,4r)-1-n-(6-chloropyridin-3-yl)-4-hydroxy-2-n-[4-(2-oxopyridin-1-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C=CC(=CC=1)N1C(C=CC=C1)=O)C(=O)NC1=CC=C(Cl)N=C1 RVWDABVOSYZSMP-QZTJIDSGSA-N 0.000 claims 1
- GZSHNQNKLDFCPB-TZIWHRDSSA-N (2r,4r)-4-acetamido-1-n-(4-chlorophenyl)-2-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)NC(=O)C)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)NC1=CC=C(Cl)C=C1 GZSHNQNKLDFCPB-TZIWHRDSSA-N 0.000 claims 1
- LHJVCEMMLRHHSK-DNVCBOLYSA-N (2r,4r)-4-amino-1-n-(4-chlorophenyl)-2-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@H](C1)N)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)NC1=CC=C(Cl)C=C1 LHJVCEMMLRHHSK-DNVCBOLYSA-N 0.000 claims 1
- JDFHFEUKMKARFL-QNFQMBCCSA-N (2r,4r)-4-ethoxy-1-[(e)-3-(1h-imidazol-5-yl)prop-2-enoyl]-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)OCC)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)\C=C\C1=CNC=N1 JDFHFEUKMKARFL-QNFQMBCCSA-N 0.000 claims 1
- DOQXMKAWISSJMU-AHKCGJDQSA-N (2r,4r)-4-ethoxy-n-[2-fluoro-4-(3-oxomorpholin-4-yl)phenyl]-1-[(e)-3-pyridin-3-ylprop-2-enoyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)OCC)C(=O)NC=1C(=CC(=CC=1)N1C(COCC1)=O)F)C(=O)\C=C\C1=CC=CN=C1 DOQXMKAWISSJMU-AHKCGJDQSA-N 0.000 claims 1
- LZDSGGQAFNMQFF-ZKMBZGGFSA-N (2r,4r)-4-ethoxy-n-[4-(3-oxomorpholin-4-yl)phenyl]-1-[(e)-3-pyridin-3-ylprop-2-enoyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)OCC)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)\C=C\C1=CC=CN=C1 LZDSGGQAFNMQFF-ZKMBZGGFSA-N 0.000 claims 1
- NXNCXBOIZCLLKD-CCLZGGOGSA-N (2r,4r)-4-ethoxy-n-[4-(3-oxomorpholin-4-yl)phenyl]-1-[(e)-3-pyridin-4-ylprop-2-enoyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)OCC)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)\C=C\C1=CC=NC=C1 NXNCXBOIZCLLKD-CCLZGGOGSA-N 0.000 claims 1
- FVENETSHUIXGOM-DYESRHJHSA-N (2r,4r)-4-hydroxy-1-(1h-indole-3-carbonyl)-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-2-carboxamide Chemical compound O=C([C@H]1C[C@H](CN1C(=O)C=1C2=CC=CC=C2NC=1)O)NC(C=C1)=CC=C1N1CCOCC1=O FVENETSHUIXGOM-DYESRHJHSA-N 0.000 claims 1
- BVVZCBQPMWPIMX-TZIWHRDSSA-N (2r,4r)-4-hydroxy-1-(1h-indole-6-carbonyl)-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-2-carboxamide Chemical compound O=C([C@H]1C[C@H](CN1C(=O)C=1C=C2NC=CC2=CC=1)O)NC(C=C1)=CC=C1N1CCOCC1=O BVVZCBQPMWPIMX-TZIWHRDSSA-N 0.000 claims 1
- WQXRTLQEABYBPG-YNDRMARASA-N (2r,4r)-4-hydroxy-1-[(e)-3-(1h-imidazol-5-yl)prop-2-enoyl]-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)\C=C\C1=CNC=N1 WQXRTLQEABYBPG-YNDRMARASA-N 0.000 claims 1
- GHDDNPBATATPJQ-NREOILKTSA-N (2r,4r)-4-hydroxy-1-[(e)-3-(5-methylfuran-2-yl)prop-2-enoyl]-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-2-carboxamide Chemical compound O1C(C)=CC=C1\C=C\C(=O)N1[C@@H](C(=O)NC=2C=CC(=CC=2)N2C(COCC2)=O)C[C@@H](O)C1 GHDDNPBATATPJQ-NREOILKTSA-N 0.000 claims 1
- IYXNVFWZCMGOED-AWEVBFKJSA-N (2r,4r)-4-hydroxy-n-[4-(3-oxomorpholin-4-yl)phenyl]-1-[(e)-3-pyridin-3-ylprop-2-enoyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)\C=C\C1=CC=CN=C1 IYXNVFWZCMGOED-AWEVBFKJSA-N 0.000 claims 1
- XEDTULQCSSZJSA-DGRSYERLSA-N (2r,4r)-4-hydroxy-n-[4-(3-oxomorpholin-4-yl)phenyl]-1-[(e)-3-pyridin-4-ylprop-2-enoyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)\C=C\C1=CC=NC=C1 XEDTULQCSSZJSA-DGRSYERLSA-N 0.000 claims 1
- RRTVMCOAJWJCFJ-RXOIRPBWSA-N (2r,4r)-4-hydroxy-n-[4-(3-oxomorpholin-4-yl)phenyl]-1-[(e)-3-thiophen-2-ylprop-2-enoyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)\C=C\C1=CC=CS1 RRTVMCOAJWJCFJ-RXOIRPBWSA-N 0.000 claims 1
- KXNWHCRRYUZPMW-JPAMVBDBSA-N (2r,4r)-4-hydroxy-n-[4-(3-oxomorpholin-4-yl)phenyl]-1-[(e)-3-thiophen-3-ylprop-2-enoyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)\C=C\C=1C=CSC=1 KXNWHCRRYUZPMW-JPAMVBDBSA-N 0.000 claims 1
- HVAWEMDIZSRQLB-VIFXATBXSA-N (2r,4r)-4-methoxy-n-[4-(3-oxomorpholin-4-yl)phenyl]-1-[(e)-3-pyridin-3-ylprop-2-enoyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)OC)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)\C=C\C1=CC=CN=C1 HVAWEMDIZSRQLB-VIFXATBXSA-N 0.000 claims 1
- NXFGSZRMRGRANB-NHCUHLMSSA-N (2r,4r)-n-(4-chlorophenyl)-4-methoxy-1-[2-[4-(3-oxomorpholin-4-yl)phenyl]acetyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)OC)C(=O)NC=1C=CC(Cl)=CC=1)C(=O)CC(C=C1)=CC=C1N1CCOCC1=O NXFGSZRMRGRANB-NHCUHLMSSA-N 0.000 claims 1
- UMZNUOGOVSOUPR-UVIKLTKHSA-N (2r,4r)-n-[2-fluoro-4-(3-oxomorpholin-4-yl)phenyl]-4-hydroxy-1-[(e)-3-pyridin-3-ylprop-2-enoyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)O)C(=O)NC=1C(=CC(=CC=1)N1C(COCC1)=O)F)C(=O)\C=C\C1=CC=CN=C1 UMZNUOGOVSOUPR-UVIKLTKHSA-N 0.000 claims 1
- FSYUXTXBUGUDSB-ZHBFVYIWSA-N (2r,4r)-n-[2-fluoro-4-(3-oxomorpholin-4-yl)phenyl]-4-methoxy-1-[(e)-3-pyridin-3-ylprop-2-enoyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@H](C1)OC)C(=O)NC=1C(=CC(=CC=1)N1C(COCC1)=O)F)C(=O)\C=C\C1=CC=CN=C1 FSYUXTXBUGUDSB-ZHBFVYIWSA-N 0.000 claims 1
- CGCSRYFJSWKMTK-AZUAARDMSA-N (2r,4s)-1-n-(4-chlorophenyl)-4-(methanesulfonamido)-2-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@@H](C1)NS(=O)(=O)C)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)NC1=CC=C(Cl)C=C1 CGCSRYFJSWKMTK-AZUAARDMSA-N 0.000 claims 1
- MILBJTXKGIUCGJ-HYBUGGRVSA-N (2r,4s)-1-n-(4-chlorophenyl)-4-ethynyl-4-hydroxy-2-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@](C1)(O)C#C)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)NC1=CC=C(Cl)C=C1 MILBJTXKGIUCGJ-HYBUGGRVSA-N 0.000 claims 1
- DMYZJLOWGSRVKP-RBUKOAKNSA-N (2r,4s)-1-n-(4-chlorophenyl)-4-hydroxy-2-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@@H](C1)O)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)NC1=CC=C(Cl)C=C1 DMYZJLOWGSRVKP-RBUKOAKNSA-N 0.000 claims 1
- XDHRGBUQUCENPC-JTHBVZDNSA-N (2r,4s)-4-(butylsulfonylamino)-1-n-(4-chlorophenyl)-2-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@@H](C1)NS(=O)(=O)CCCC)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)NC1=CC=C(Cl)C=C1 XDHRGBUQUCENPC-JTHBVZDNSA-N 0.000 claims 1
- GNHDNOXIDAHDBQ-RBBKRZOGSA-N (2r,4s)-4-acetamido-1-n-(4-chlorophenyl)-2-n-[3-methyl-4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@@H](C1)NC(=O)C)C(=O)NC=1C=C(C)C(N2C(COCC2)=O)=CC=1)C(=O)NC1=CC=C(Cl)C=C1 GNHDNOXIDAHDBQ-RBBKRZOGSA-N 0.000 claims 1
- GZSHNQNKLDFCPB-PZJWPPBQSA-N (2r,4s)-4-acetamido-1-n-(4-chlorophenyl)-2-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@H](C[C@@H](C1)NC(=O)C)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)NC1=CC=C(Cl)C=C1 GZSHNQNKLDFCPB-PZJWPPBQSA-N 0.000 claims 1
- SOOORKSHYAFKEK-OXJNMPFZSA-N (2r,4s)-4-amino-1-n-(4-chlorophenyl)-2-n-[3-methyl-4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound C([C@@H](N)C[C@@H]1C(=O)NC=2C=C(C(=CC=2)N2C(COCC2)=O)C)N1C(=O)NC1=CC=C(Cl)C=C1 SOOORKSHYAFKEK-OXJNMPFZSA-N 0.000 claims 1
- NXFGSZRMRGRANB-LEWJYISDSA-N (2r,4s)-n-(4-chlorophenyl)-4-methoxy-1-[2-[4-(3-oxomorpholin-4-yl)phenyl]acetyl]pyrrolidine-2-carboxamide Chemical compound N1([C@H](C[C@@H](C1)OC)C(=O)NC=1C=CC(Cl)=CC=1)C(=O)CC(C=C1)=CC=C1N1CCOCC1=O NXFGSZRMRGRANB-LEWJYISDSA-N 0.000 claims 1
- FJDROJBPSMOTGQ-FQEVSTJZSA-N (2s)-1-n-(4-chlorophenyl)-2-n-[3-methyl-4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound C([C@H]1C(=O)NC=2C=C(C(=CC=2)N2C(COCC2)=O)C)CCN1C(=O)NC1=CC=C(Cl)C=C1 FJDROJBPSMOTGQ-FQEVSTJZSA-N 0.000 claims 1
- RSTITRFVOKEISD-IBGZPJMESA-N (2s)-2-n-(4-chlorophenyl)-1-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)[C@H]1N(C(=O)NC=2C=CC(=CC=2)N2C(COCC2)=O)CCC1 RSTITRFVOKEISD-IBGZPJMESA-N 0.000 claims 1
- OPKNCNJKZZZIAB-ICSRJNTNSA-N (2s,3s)-1-n-(4-chlorophenyl)-3-hydroxy-2-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound O=C([C@H]1N(CC[C@@H]1O)C(=O)NC=1C=CC(Cl)=CC=1)NC(C=C1)=CC=C1N1CCOCC1=O OPKNCNJKZZZIAB-ICSRJNTNSA-N 0.000 claims 1
- DMYZJLOWGSRVKP-MOPGFXCFSA-N (2s,4r)-1-n-(4-chlorophenyl)-4-hydroxy-2-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@@H](C[C@H](C1)O)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)NC1=CC=C(Cl)C=C1 DMYZJLOWGSRVKP-MOPGFXCFSA-N 0.000 claims 1
- NXFGSZRMRGRANB-RTWAWAEBSA-N (2s,4r)-n-(4-chlorophenyl)-4-methoxy-1-[2-[4-(3-oxomorpholin-4-yl)phenyl]acetyl]pyrrolidine-2-carboxamide Chemical compound N1([C@@H](C[C@H](C1)OC)C(=O)NC=1C=CC(Cl)=CC=1)C(=O)CC(C=C1)=CC=C1N1CCOCC1=O NXFGSZRMRGRANB-RTWAWAEBSA-N 0.000 claims 1
- DMYZJLOWGSRVKP-OALUTQOASA-N (2s,4s)-1-n-(4-chlorophenyl)-4-hydroxy-2-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound N1([C@@H](C[C@@H](C1)O)C(=O)NC=1C=CC(=CC=1)N1C(COCC1)=O)C(=O)NC1=CC=C(Cl)C=C1 DMYZJLOWGSRVKP-OALUTQOASA-N 0.000 claims 1
- DUWPINDOUUJUCH-LJQANCHMSA-N (4r)-3-n-(4-chlorophenyl)-4-n-[3-methyl-4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidine-3,4-dicarboxamide Chemical compound C([C@@H]1C(=O)NC=2C=C(C(=CC=2)N2C(COCC2)=O)C)OCN1C(=O)NC1=CC=C(Cl)C=C1 DUWPINDOUUJUCH-LJQANCHMSA-N 0.000 claims 1
- IYJCHOILWNXQGR-GOSISDBHSA-N (4r)-3-n-(4-chlorophenyl)-4-n-[4-(2-oxopyrazin-1-yl)phenyl]-1,3-oxazolidine-3,4-dicarboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)N1[C@@H](C(=O)NC=2C=CC(=CC=2)N2C(C=NC=C2)=O)COC1 IYJCHOILWNXQGR-GOSISDBHSA-N 0.000 claims 1
- AKLQCCBKTXDXQB-LJQANCHMSA-N (4r)-3-n-(4-chlorophenyl)-4-n-[4-(2-oxopyridin-1-yl)phenyl]-1,3-oxazolidine-3,4-dicarboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)N1[C@@H](C(=O)NC=2C=CC(=CC=2)N2C(C=CC=C2)=O)COC1 AKLQCCBKTXDXQB-LJQANCHMSA-N 0.000 claims 1
- RPYZHDVFFYLTII-IBGZPJMESA-N (4r)-3-n-(4-chlorophenyl)-4-n-[4-(2-oxopyridin-1-yl)phenyl]-1,3-thiazolidine-3,4-dicarboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)N1[C@H](C(=O)NC=2C=CC(=CC=2)N2C(C=CC=C2)=O)CSC1 RPYZHDVFFYLTII-IBGZPJMESA-N 0.000 claims 1
- YPQLIXKIXJTNFS-GOSISDBHSA-N (4r)-3-n-(4-chlorophenyl)-4-n-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidine-3,4-dicarboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)N1[C@@H](C(=O)NC=2C=CC(=CC=2)N2C(COCC2)=O)COC1 YPQLIXKIXJTNFS-GOSISDBHSA-N 0.000 claims 1
- VELWROWHHBGVQD-LJQANCHMSA-N (4r)-4-n-[3-chloro-4-(2-oxopyridin-1-yl)phenyl]-3-n-(4-chlorophenyl)-1,3-oxazolidine-3,4-dicarboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)N1[C@@H](C(=O)NC=2C=C(Cl)C(=CC=2)N2C(C=CC=C2)=O)COC1 VELWROWHHBGVQD-LJQANCHMSA-N 0.000 claims 1
- GMQMVDUDCXGWMZ-QVKFZJNVSA-N (4r,5r)-3-n-(4-chlorophenyl)-5-methyl-4-n-[3-methyl-4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidine-3,4-dicarboxamide Chemical compound O=C([C@@H]1N(CO[C@@H]1C)C(=O)NC=1C=CC(Cl)=CC=1)NC(C=C1C)=CC=C1N1CCOCC1=O GMQMVDUDCXGWMZ-QVKFZJNVSA-N 0.000 claims 1
- YNVXMLRUWXKFBE-RNODOKPDSA-N (4r,5s)-3-n-(4-chlorophenyl)-4-n-[3-fluoro-4-(3-oxomorpholin-4-yl)phenyl]-5-methyl-1,3-oxazolidine-3,4-dicarboxamide Chemical compound O=C([C@@H]1N(CO[C@H]1C)C(=O)NC=1C=CC(Cl)=CC=1)NC(C=C1F)=CC=C1N1CCOCC1=O YNVXMLRUWXKFBE-RNODOKPDSA-N 0.000 claims 1
- GMQMVDUDCXGWMZ-YCRPNKLZSA-N (4r,5s)-3-n-(4-chlorophenyl)-5-methyl-4-n-[3-methyl-4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidine-3,4-dicarboxamide Chemical compound O=C([C@@H]1N(CO[C@H]1C)C(=O)NC=1C=CC(Cl)=CC=1)NC(C=C1C)=CC=C1N1CCOCC1=O GMQMVDUDCXGWMZ-YCRPNKLZSA-N 0.000 claims 1
- MRXVLTANYWRRHM-VBKZILBWSA-N (4r,5s)-3-n-(4-chlorophenyl)-5-methyl-4-n-[4-(2-oxopyrazin-1-yl)phenyl]-1,3-oxazolidine-3,4-dicarboxamide Chemical compound O=C([C@@H]1N(CO[C@H]1C)C(=O)NC=1C=CC(Cl)=CC=1)NC(C=C1)=CC=C1N1C=CN=CC1=O MRXVLTANYWRRHM-VBKZILBWSA-N 0.000 claims 1
- KGFSABCWQRXYGQ-YCRPNKLZSA-N (4r,5s)-3-n-(4-chlorophenyl)-5-methyl-4-n-[4-(2-oxopyridin-1-yl)phenyl]-1,3-oxazolidine-3,4-dicarboxamide Chemical compound O=C([C@@H]1N(CO[C@H]1C)C(=O)NC=1C=CC(Cl)=CC=1)NC(C=C1)=CC=C1N1C=CC=CC1=O KGFSABCWQRXYGQ-YCRPNKLZSA-N 0.000 claims 1
- YHAWVVHONBWGKM-VBKZILBWSA-N (4r,5s)-3-n-(4-chlorophenyl)-5-methyl-4-n-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidine-3,4-dicarboxamide Chemical compound O=C([C@@H]1N(CO[C@H]1C)C(=O)NC=1C=CC(Cl)=CC=1)NC(C=C1)=CC=C1N1CCOCC1=O YHAWVVHONBWGKM-VBKZILBWSA-N 0.000 claims 1
- QZSPCVMXDIHDGW-RNODOKPDSA-N (4r,5s)-4-n-[3-chloro-4-(3-oxomorpholin-4-yl)phenyl]-3-n-(4-chlorophenyl)-5-methyl-1,3-oxazolidine-3,4-dicarboxamide Chemical compound O=C([C@@H]1N(CO[C@H]1C)C(=O)NC=1C=CC(Cl)=CC=1)NC(C=C1Cl)=CC=C1N1CCOCC1=O QZSPCVMXDIHDGW-RNODOKPDSA-N 0.000 claims 1
- NXBFMPLWTBYRAO-GOSISDBHSA-N (4s)-3-n-(4-chlorophenyl)-1,1-dioxo-4-n-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-thiazolidine-3,4-dicarboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)N1[C@@H](C(=O)NC=2C=CC(=CC=2)N2C(COCC2)=O)CS(=O)(=O)C1 NXBFMPLWTBYRAO-GOSISDBHSA-N 0.000 claims 1
- PLCWVBPQNVRXMQ-LJQANCHMSA-N (4s)-3-n-(4-chlorophenyl)-4-n-[3-methyl-4-(3-oxomorpholin-4-yl)phenyl]-1,1-dioxo-1,3-thiazolidine-3,4-dicarboxamide Chemical compound C([C@@H]1C(=O)NC=2C=C(C(=CC=2)N2C(COCC2)=O)C)S(=O)(=O)CN1C(=O)NC1=CC=C(Cl)C=C1 PLCWVBPQNVRXMQ-LJQANCHMSA-N 0.000 claims 1
- BRMKYFOJUJGHTK-LJQANCHMSA-N (4s)-3-n-(4-chlorophenyl)-4-n-[3-methyl-4-(3-oxomorpholin-4-yl)phenyl]-1,3-thiazolidine-3,4-dicarboxamide Chemical compound C([C@@H]1C(=O)NC=2C=C(C(=CC=2)N2C(COCC2)=O)C)SCN1C(=O)NC1=CC=C(Cl)C=C1 BRMKYFOJUJGHTK-LJQANCHMSA-N 0.000 claims 1
- OUGSWDZAABYPQG-GOSISDBHSA-N (4s)-3-n-(4-chlorophenyl)-4-n-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-thiazolidine-3,4-dicarboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)N1[C@@H](C(=O)NC=2C=CC(=CC=2)N2C(COCC2)=O)CSC1 OUGSWDZAABYPQG-GOSISDBHSA-N 0.000 claims 1
- LNSWHSWNANIITD-UHFFFAOYSA-N 1-n-(4-chlorophenyl)-2-n-[4-(3-oxomorpholin-4-yl)phenyl]piperazine-1,2-dicarboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)N1C(C(=O)NC=2C=CC(=CC=2)N2C(COCC2)=O)CNCC1 LNSWHSWNANIITD-UHFFFAOYSA-N 0.000 claims 1
- OOLHEGBMCONDON-UHFFFAOYSA-N 1-n-(4-chlorophenyl)-3,4-dihydroxy-2-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound OC1C(O)CN(C(=O)NC=2C=CC(Cl)=CC=2)C1C(=O)NC(C=C1)=CC=C1N1CCOCC1=O OOLHEGBMCONDON-UHFFFAOYSA-N 0.000 claims 1
- KMXYMVJJXYMMTQ-UHFFFAOYSA-N 4-n-(4-chlorophenyl)-5-n-[4-(2-oxopyridin-1-yl)phenyl]-1,3-dioxolane-4,5-dicarboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)C1C(C(=O)NC=2C=CC(=CC=2)N2C(C=CC=C2)=O)OCO1 KMXYMVJJXYMMTQ-UHFFFAOYSA-N 0.000 claims 1
- IXBOFHALXIQKFW-UHFFFAOYSA-N 4-n-(4-chlorophenyl)-5-n-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-dioxolane-4,5-dicarboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)C1C(C(=O)NC=2C=CC(=CC=2)N2C(COCC2)=O)OCO1 IXBOFHALXIQKFW-UHFFFAOYSA-N 0.000 claims 1
- UCHFQSHOMSOXMP-UHFFFAOYSA-N 5-n-(4-chlorophenyl)-4-n-[3-methyl-4-(3-oxomorpholin-4-yl)phenyl]-1,3-dioxolane-4,5-dicarboxamide Chemical compound C=1C=C(N2C(COCC2)=O)C(C)=CC=1NC(=O)C1OCOC1C(=O)NC1=CC=C(Cl)C=C1 UCHFQSHOMSOXMP-UHFFFAOYSA-N 0.000 claims 1
- 150000003857 carboxamides Chemical class 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- OJPKZAUSOYYUOW-AUSIDOKSSA-N (2r,4r)-1-n-(4-chlorophenyl)-4-hydroxy-2-methyl-2-n-[4-(3-oxomorpholin-4-yl)phenyl]pyrrolidine-1,2-dicarboxamide Chemical compound C([C@H](O)C[C@]1(C)C(=O)NC=2C=CC(=CC=2)N2C(COCC2)=O)N1C(=O)NC1=CC=C(Cl)C=C1 OJPKZAUSOYYUOW-AUSIDOKSSA-N 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- VZEYHVUJKMPUGX-GOEBONIOSA-N diazonio-[(3s,5r)-1-[(2-methylpropan-2-yl)oxycarbonyl]-5-[[4-(3-oxomorpholin-4-yl)phenyl]carbamoyl]pyrrolidin-3-yl]azanide Chemical compound CC(C)(C)OC(=O)N1C[C@@H](N=[N+]=[N-])C[C@@H]1C(=O)NC1=CC=C(N2C(COCC2)=O)C=C1 VZEYHVUJKMPUGX-GOEBONIOSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002953 preparative HPLC Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- FIQMHBFVRAXMOP-UHFFFAOYSA-N triphenylphosphane oxide Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=O)C1=CC=CC=C1 FIQMHBFVRAXMOP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10315377A DE10315377A1 (de) | 2003-04-03 | 2003-04-03 | Carbonylverbindungen |
| DE10315377.2 | 2003-04-03 | ||
| DE10329295.0 | 2003-06-30 | ||
| DE2003129295 DE10329295A1 (de) | 2003-06-30 | 2003-06-30 | Carbonylverbindungen |
| US48389703P | 2003-07-02 | 2003-07-02 | |
| US60/483,897 | 2003-07-02 | ||
| PCT/EP2004/002350 WO2004087646A2 (de) | 2003-04-03 | 2004-03-08 | Pyrrolidin -1,2-dicarbonsäure-1-(phenylamid) -2- (4-(3-oxo-morpholin-4-yl)-phenylamid) derivate und verwandte verbindungen als inhibitoren des koagulationsfaktors xa zur behandlung von thromboembolischen erkrankungen |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006522033A JP2006522033A (ja) | 2006-09-28 |
| JP2006522033A5 true JP2006522033A5 (https=) | 2007-04-26 |
| JP4705015B2 JP4705015B2 (ja) | 2011-06-22 |
Family
ID=33135449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006504581A Expired - Fee Related JP4705015B2 (ja) | 2003-04-03 | 2004-03-08 | カルボニル化合物 |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US7906516B2 (https=) |
| EP (1) | EP1720844B1 (https=) |
| JP (1) | JP4705015B2 (https=) |
| KR (1) | KR20050118708A (https=) |
| AR (1) | AR043832A1 (https=) |
| AT (1) | ATE430139T1 (https=) |
| AU (1) | AU2004226278B2 (https=) |
| BR (1) | BRPI0408420A (https=) |
| CA (1) | CA2521069C (https=) |
| CL (1) | CL2004000720A1 (https=) |
| CO (1) | CO5660267A2 (https=) |
| DE (1) | DE502004009440D1 (https=) |
| EC (1) | ECSP056131A (https=) |
| ES (1) | ES2325077T3 (https=) |
| IL (1) | IL171214A (https=) |
| MX (1) | MXPA05010444A (https=) |
| MY (1) | MY140031A (https=) |
| NZ (1) | NZ543366A (https=) |
| PE (1) | PE20050015A1 (https=) |
| PL (1) | PL377633A1 (https=) |
| TW (1) | TW200512200A (https=) |
| WO (1) | WO2004087646A2 (https=) |
Families Citing this family (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10358814A1 (de) | 2003-12-16 | 2005-07-21 | Merck Patent Gmbh | Prolinylarylacetamide |
| JP4769082B2 (ja) * | 2003-12-17 | 2011-09-07 | 武田薬品工業株式会社 | ウレア誘導体、その製造法及び用途 |
| WO2006022442A1 (ja) * | 2004-08-24 | 2006-03-02 | Santen Pharmaceutical Co., Ltd. | ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体 |
| DE102004045796A1 (de) * | 2004-09-22 | 2006-03-23 | Merck Patent Gmbh | Arzneimittel enthaltend Carbonylverbindungen sowie deren Verwendung |
| DE102004047254A1 (de) * | 2004-09-29 | 2006-04-13 | Merck Patent Gmbh | Carbonylverbindungen |
| US20080194643A1 (en) | 2005-03-24 | 2008-08-14 | Pfzer Inc | Factor Xa Inhibitor Crystalline Forms |
| US7820699B2 (en) * | 2005-04-27 | 2010-10-26 | Hoffmann-La Roche Inc. | Cyclic amines |
| CA2627426A1 (en) * | 2005-11-11 | 2007-05-18 | Markus Boehringer | Carbocyclic fused cyclic amines as inhibitors of the coagulation factor xa |
| EP1951717A1 (en) * | 2005-11-16 | 2008-08-06 | F.Hoffmann-La Roche Ag | Novel pyrrolidine derivatives as inhibitors of coagulation factor xa |
| UA96283C2 (uk) | 2005-12-23 | 2011-10-25 | Зіланд Фарма А/С | Модифіковані міметики лізину |
| EP2007377A4 (en) * | 2006-04-06 | 2011-08-17 | Glaxo Group Ltd | ANTIBACTERIAL ACTIVE SUBSTANCES |
| USRE50453E1 (en) | 2006-04-07 | 2025-06-10 | Vertex Pharmaceuticals Incorporated | Indole derivatives as CFTR modulators |
| EP2674428B1 (en) | 2006-04-07 | 2016-04-06 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
| US10022352B2 (en) | 2006-04-07 | 2018-07-17 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
| US7645789B2 (en) | 2006-04-07 | 2010-01-12 | Vertex Pharmaceuticals Incorporated | Indole derivatives as CFTR modulators |
| MY146623A (en) | 2006-05-16 | 2012-09-14 | Boehringer Ingelheim Int | Substituted prolinamides, manufacturing, and the use thereof as medicaments |
| DK2076508T3 (da) | 2006-10-18 | 2011-02-21 | Pfizer Prod Inc | Biaryl-ether-urinstof-forbindelser |
| US8563573B2 (en) | 2007-11-02 | 2013-10-22 | Vertex Pharmaceuticals Incorporated | Azaindole derivatives as CFTR modulators |
| PL2468724T3 (pl) | 2006-12-21 | 2016-05-31 | Zealand Pharma As | Synteza związków pirolidynowych |
| TW200911787A (en) * | 2007-07-03 | 2009-03-16 | Astrazeneca Ab | New aza-bicyclohexane compounds useful as inhibitors of thrombin |
| DE102008020053A1 (de) * | 2008-04-22 | 2009-10-29 | Merck Patent Gmbh | Feste pharmazeutische Zubereitung enthaltend 1-[(4-chloro-phenyl)-amid]-2-{[4-(3-oxo-morpholin-4-yl)-phenyl]-amid}-4-hydroxy-pyrrolidin-1,2-dicarbonsäure |
| WO2009136625A1 (ja) | 2008-05-07 | 2009-11-12 | 大日本住友製薬株式会社 | 環状アミン－１－カルボン酸エステル誘導体およびそれを含有する医薬組成物 |
| US8673920B2 (en) | 2009-05-06 | 2014-03-18 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| JP2013503163A (ja) * | 2009-08-31 | 2013-01-31 | 持田製薬株式会社 | 第ＩＸａ因子阻害薬としてのモルホリノン化合物 |
| US8802868B2 (en) | 2010-03-25 | 2014-08-12 | Vertex Pharmaceuticals Incorporated | Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide |
| MX353408B (es) | 2010-04-22 | 2018-01-11 | Vertex Pharma | Proceso para producir compuestos de cicloalquilcarboxamido-indol. |
| WO2012058116A1 (en) | 2010-10-27 | 2012-05-03 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| EP2632464B1 (en) | 2010-10-29 | 2015-04-29 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| EP2661433B1 (en) | 2011-01-04 | 2017-08-16 | Novartis AG | Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (amd) |
| AU2012299227A1 (en) | 2011-08-19 | 2014-02-20 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| US8883819B2 (en) | 2011-09-01 | 2014-11-11 | Irm Llc | Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension |
| WO2013039802A1 (en) | 2011-09-16 | 2013-03-21 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| US8999990B2 (en) | 2011-10-25 | 2015-04-07 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| EP2771004B1 (en) | 2011-10-25 | 2016-05-18 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| EP2773351B1 (en) | 2011-10-31 | 2017-08-23 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| WO2013066714A1 (en) | 2011-10-31 | 2013-05-10 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| EP2773206B1 (en) | 2011-10-31 | 2018-02-21 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| EP2790511B1 (en) | 2011-12-16 | 2016-09-14 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| JP5903499B2 (ja) | 2011-12-22 | 2016-04-13 | ノバルティス アーゲー | ジヒドロ−ベンゾ−オキサジンおよびジヒドロ−ピリド−オキサジン誘導体 |
| JP2015083542A (ja) * | 2012-02-08 | 2015-04-30 | 大日本住友製薬株式会社 | ３位置換プロリン誘導体 |
| ES2644700T3 (es) | 2012-06-28 | 2017-11-30 | Novartis Ag | Derivados de pirrolidina y su uso como moduladores de la ruta del complemento |
| WO2014002054A1 (en) | 2012-06-28 | 2014-01-03 | Novartis Ag | Pyrrolidine derivatives and their use as complement pathway modulators |
| JP6273274B2 (ja) | 2012-06-28 | 2018-01-31 | ノバルティス アーゲー | 補体経路モジュレーターおよびその使用 |
| JP6214647B2 (ja) | 2012-06-28 | 2017-10-18 | ノバルティス アーゲー | 補体経路モジュレーターおよびその使用 |
| CN104379579B (zh) | 2012-06-28 | 2017-03-08 | 诺华股份有限公司 | 吡咯烷衍生物及其作为补体途径调节剂的用途 |
| WO2014009833A2 (en) | 2012-07-12 | 2014-01-16 | Novartis Ag | Complement pathway modulators and uses thereof |
| AR092857A1 (es) | 2012-07-16 | 2015-05-06 | Vertex Pharma | Composiciones farmaceuticas de (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-il)-n-(1-(2,3-dihidroxipropil)-6-fluoro-2-(1-hidroxi-2-metilpropan-2-il)-1h-indol-5-il)ciclopropancarboxamida y administracion de las mismas |
| US9758480B2 (en) | 2012-07-19 | 2017-09-12 | Sumitomo Dainippon Pharma Co., Ltd. | 1-(cycloalkyl-carbonyl)proline derivative |
| AR092031A1 (es) | 2012-07-26 | 2015-03-18 | Merck Sharp & Dohme | Inhibidores del canal de potasio medular externo renal |
| EP2925322B1 (en) | 2012-11-29 | 2018-10-24 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| US9573961B2 (en) | 2012-12-19 | 2017-02-21 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| WO2014126944A2 (en) | 2013-02-18 | 2014-08-21 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| US9073921B2 (en) | 2013-03-01 | 2015-07-07 | Novartis Ag | Salt forms of bicyclic heterocyclic derivatives |
| EP2968288B1 (en) | 2013-03-15 | 2018-07-04 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| EP3027625B1 (en) | 2013-07-31 | 2018-05-30 | Merck Sharp & Dohme Corp. | Spiro-fused derivatives of piperidine useful for the treatment of inter alia hypertension and acute or chronic heart failure |
| WO2015065866A1 (en) | 2013-10-31 | 2015-05-07 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| KR20160107322A (ko) * | 2014-01-14 | 2016-09-13 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 축합 ５－옥사졸리디논 유도체 |
| RU2744460C2 (ru) | 2014-04-15 | 2021-03-09 | Вертекс Фармасьютикалз Инкорпорейтед | Фармацевтические композиции для лечения заболеваний, опосредованных муковисцидозным трансмембранным регулятором проводимости |
| WO2016127358A1 (en) | 2015-02-12 | 2016-08-18 | Merck Sharp & Dohme Corp. | Inhibitors of renal outer medullary potassium channel |
| US10669528B2 (en) | 2015-06-25 | 2020-06-02 | Children's Medical Center Corporation | Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance |
| MY198346A (en) | 2015-10-01 | 2023-08-28 | Biocryst Pharm Inc | Human plasma kallikrein inhibitors |
| CN108289448B (zh) | 2015-12-02 | 2021-10-22 | 先正达参股股份有限公司 | 杀微生物的噁二唑衍生物 |
| WO2017161001A1 (en) | 2016-03-15 | 2017-09-21 | Children's Medical Center Corporation | Methods and compositions relating to hematopoietic stem cell expansion |
| JP6989864B2 (ja) | 2017-05-05 | 2022-02-03 | ジーランド ファーマ，アー／エス | ギャップ結合細胞間コミュニケーションモジュレータ及び糖尿病性眼疾患の治療のためのそれらの使用 |
| WO2018219773A1 (en) | 2017-06-02 | 2018-12-06 | Syngenta Participations Ag | Fungicidal compositions |
| EP3630753A1 (en) | 2017-06-02 | 2020-04-08 | Syngenta Participations AG | Microbiocidal oxadiazole derivatives |
| WO2026078617A1 (en) * | 2024-10-11 | 2026-04-16 | Pfizer Inc. | Glucose-dependent insulinotropic polypeptide receptor antagonists and uses thereof |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1076114A (en) * | 1975-02-10 | 1980-04-22 | Mitsubishi Chemical Industries Limited | 1,5-alkylene-3-aryl hydantoin derivatives |
| ZA951617B (en) * | 1994-03-04 | 1997-02-27 | Lilly Co Eli | Antithrombotic agents. |
| US5705487A (en) | 1994-03-04 | 1998-01-06 | Eli Lilly And Company | Antithrombotic agents |
| US5691356A (en) * | 1994-03-21 | 1997-11-25 | Bristol-Myers Squibb Company | Disubstituted heterocyclic thrombin inhibitors |
| ATE272633T1 (de) * | 1998-12-23 | 2004-08-15 | Lilly Co Eli | Aromatische amiden |
| US6673817B1 (en) | 1999-05-24 | 2004-01-06 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
| EP1185512A2 (en) * | 1999-05-24 | 2002-03-13 | Cor Therapeutics, Inc. | INHIBITORS OF FACTOR Xa |
| AU2001250783A1 (en) | 2000-02-29 | 2001-09-12 | Cor Therapeutics, Inc. | Benzamides and related inhibitors of factor xa |
| ATE308540T1 (de) | 2000-08-17 | 2005-11-15 | Lilly Co Eli | Antithrombosemittel |
| US6838479B2 (en) | 2000-09-11 | 2005-01-04 | Genentech, Inc. | Amidine inhibitors of serine proteases |
| DE10063008A1 (de) | 2000-12-16 | 2002-06-20 | Merck Patent Gmbh | Carbonsäureamidderivate |
| DE10102322A1 (de) * | 2001-01-19 | 2002-07-25 | Merck Patent Gmbh | Phenylderivate |
| DE10113402A1 (de) | 2001-03-20 | 2002-09-26 | Merck Patent Gmbh | Biurethanderivate |
| PL208928B1 (pl) * | 2001-04-16 | 2011-06-30 | Pharmacopeia | 3, 4-di-podstawione cyklobuten-1, 2-diony jako ligandy receptora CXC chemokiny |
| US20040097547A1 (en) | 2001-04-16 | 2004-05-20 | Taveras Arthur G. | 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| US7030141B2 (en) | 2001-11-29 | 2006-04-18 | Christopher Franklin Bigge | Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| US7449457B2 (en) * | 2001-12-07 | 2008-11-11 | Eli Lilly And Company | Substituted heterocyclic carboxamides with antithrombotic activity |
-
2004
- 2004-03-08 PL PL377633A patent/PL377633A1/pl not_active Application Discontinuation
- 2004-03-08 MX MXPA05010444A patent/MXPA05010444A/es active IP Right Grant
- 2004-03-08 AU AU2004226278A patent/AU2004226278B2/en not_active Ceased
- 2004-03-08 AT AT04718299T patent/ATE430139T1/de not_active IP Right Cessation
- 2004-03-08 DE DE502004009440T patent/DE502004009440D1/de not_active Expired - Lifetime
- 2004-03-08 CA CA2521069A patent/CA2521069C/en not_active Expired - Fee Related
- 2004-03-08 NZ NZ543366A patent/NZ543366A/en unknown
- 2004-03-08 BR BRPI0408420-9A patent/BRPI0408420A/pt not_active IP Right Cessation
- 2004-03-08 JP JP2006504581A patent/JP4705015B2/ja not_active Expired - Fee Related
- 2004-03-08 EP EP04718299A patent/EP1720844B1/de not_active Expired - Lifetime
- 2004-03-08 US US10/551,557 patent/US7906516B2/en not_active Expired - Fee Related
- 2004-03-08 ES ES04718299T patent/ES2325077T3/es not_active Expired - Lifetime
- 2004-03-08 WO PCT/EP2004/002350 patent/WO2004087646A2/de not_active Ceased
- 2004-03-08 KR KR1020057018638A patent/KR20050118708A/ko not_active Withdrawn
- 2004-03-31 MY MYPI20041185A patent/MY140031A/en unknown
- 2004-03-31 TW TW093108890A patent/TW200512200A/zh unknown
- 2004-04-02 AR ARP040101114A patent/AR043832A1/es not_active Application Discontinuation
- 2004-04-02 PE PE2004000350A patent/PE20050015A1/es not_active Application Discontinuation
- 2004-04-02 CL CL200400720A patent/CL2004000720A1/es unknown
-
2005
- 2005-09-29 IL IL171214A patent/IL171214A/en not_active IP Right Cessation
- 2005-10-03 CO CO05099907A patent/CO5660267A2/es not_active Application Discontinuation
- 2005-10-28 EC EC2005006131A patent/ECSP056131A/es unknown
-
2010
- 2010-06-17 US US12/817,314 patent/US8129373B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006522033A5 (https=) | ||
| AU2017276170B2 (en) | Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of Hepatitis B | |
| DK1757582T3 (en) | Arylalkylamines AND MANUFACTURING METHOD THEREOF | |
| KR100817378B1 (ko) | 프롤린 유도체 및 그 의약 용도 | |
| CA2521069A1 (en) | Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases | |
| CN116096714A (zh) | 用于治疗冠状病毒、小核糖核酸病毒和诺罗病毒感染的抗病毒化合物 | |
| KR101072236B1 (ko) | 디펩티딜 펩티다제-ｉｖ(ｄｐｐ-ｉｖ)의 억제제로서의약제학적 조성물 | |
| KR101320790B1 (ko) | 카텝신 억제제로서의 프롤린 유도체 | |
| MXPA05008449A (es) | N-arilheterociclos sustituidos, procedimientos para su preparacion, y su empleo como medicamentos. | |
| ES2349428T3 (es) | Derivados de fenilglicinamida útiles como anticoagulantes. | |
| WO2011068941A2 (en) | Proline derivatives | |
| JP2006306886A (ja) | ジペプチジルペプチダーゼ阻害剤としてのフルオロピロリジン類 | |
| BRPI0710467A2 (pt) | composto, composição farmacêutica, uso de um composto, e, intermediário | |
| CA2739875A1 (en) | Pyrrolidine compounds which inhibit beta-secretase activity and methods of use thereof | |
| WO2024081318A1 (en) | Anti-viral compounds | |
| KR100847191B1 (ko) | 피롤리딘-3,4-다이카복스아마이드 유도체 | |
| WO2004018453A1 (ja) | プロリン誘導体 | |
| EP2486006A1 (en) | Sulfonamido pyrrolidine compounds which inhibit beta-secretase activity and methods of use thereof | |
| EP2411000A1 (en) | Pyrrolidine compounds which inhibit beta-secretase activity and methods of use thereof | |
| RU2005141519A (ru) | Производные ароилсемикарбазида против тромбоэмболических заболеваний | |
| RU2005133869A (ru) | Производные 1-n-(фенил)-2-n-(фенил)пиразолидин-1, 2-дикарбоксамида в качестве ингибиторов фактора коагуляции ха для лечения тромбозов | |
| DE10329295A1 (de) | Carbonylverbindungen |